Germline TP53mutations in Finnish breast cancer patients

被引：0
|
作者：
K Rapakko
M Allinen
K Syrjäkoski
P Vahteristo
P Huusko
K Vähäkangas
H Eerola
T Kainu
O-P Kallioniemi
H Nevanlinna
R Winqvist
机构：
[1] Departments of Clinical Genetics,Pharmacology and Toxicology
[2] University of Oulu/Oulu University Hospital,Laboratory of Cancer Genetics, Institute of Medical Technology
[3] Tampere University Hospital,Oncology
[4] Departments of Obstetrics and Gynecology,undefined
[5] Helsinki University Central Hospital,undefined
来源：
Breast Cancer Research | / 2卷 / Suppl 1期
关键词：
Breast Cancer; Breast Cancer Patient; Breast Cancer Case; Cancer Family; Female Breast Cancer;
D O I：
10.1186/bcr98
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    [J]. TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [2] Prognostic value genotypes and LOH at TP53 codon 72 and TP53mutations in primary breast cancer
    M Kyndi
    J Alsner
    LL Hansen
    FB Sørensen
    J Overgaard
    [J]. Breast Cancer Research, 7
  • [3] Clinical implications of germline mutations in breast cancer: TP53
    Schon, Katherine
    Tischkowitz, Marc
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 417 - 423
  • [4] Clinical implications of germline mutations in breast cancer: TP53
    Katherine Schon
    Marc Tischkowitz
    [J]. Breast Cancer Research and Treatment, 2018, 167 : 417 - 423
  • [5] Prevalence of germline TP53 mutations in HER2+ breast cancer patients
    Michelle G. Rath
    Serena Masciari
    Rebecca Gelman
    Alexander Miron
    Penelope Miron
    Kathleen Foley
    Andrea L. Richardson
    Ian E. Krop
    Sigitas J. Verselis
    Deborah A. Dillon
    Judy E. Garber
    [J]. Breast Cancer Research and Treatment, 2013, 139 : 193 - 198
  • [6] Prevalence of germline TP53 mutations in HER2+breast cancer patients
    Rath, Michelle G.
    Masciari, Serena
    Gelman, Rebecca
    Miron, Alexander
    Miron, Penelope
    Foley, Kathleen
    Richardson, Andrea L.
    Krop, Ian E.
    Verselis, Sigitas J.
    Dillon, Deborah A.
    Garber, Judy E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (01) : 193 - 198
  • [7] TP53mutations promote death of breast cancer cells following Kif11 inhibition
    Lanier, Amanda L.
    Tahaney, William
    Qian, Jing
    Moyer, Cassandra
    Ma, Yanxia
    Arun, Banu
    Mazumdar, Abhijit
    Brown, Powel H.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
    Alyami, Hassan
    Yoo, Tae Kyung
    Cheun, Jong Ho
    Lee, Han Byoel
    Jung, Sung Mi
    Ryu, Jai Min
    Bae, Soong June
    Jeong, Joon
    Yoon, Chang Ik
    Ahn, Juneyoung
    Paik, Pill Sun
    Cho, Min Kyung
    Park, Woo Chan
    [J]. JOURNAL OF BREAST CANCER, 2021, 24 (02) : 175 - 182
  • [9] Impact of germline TP53 mutations and polymorphisms in women with premenopausal breast cancer
    Samuel, Nardin
    Novokmet, Ana
    Hudson, Thomas J.
    Malkin, David
    [J]. CANCER RESEARCH, 2014, 74 (23)
  • [10] Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
    Ava Kwong
    Vivian Yvonne Shin
    Cecilia Y. S. Ho
    Chun Hang Au
    Thomas P. Slavin
    Jeffrey N. Weitzel
    Tsun-Leung Chan
    Edmond S. K. Ma
    [J]. BMC Cancer, 20
12345